Hepatology

A novel automated speech analysis platform has been developed to test for minimal hepatic encephalopathy (HE) and to predict overt HE in patients with cirrhosis. 

Researchers have discovered that the use of glucagon-like peptide 1 receptor agonists in patients with MASLD is linked to a significant reduction in the risk of developing cirrhosis and its complications. 

Declines in serum hepatitis B virus RNA during the first and second year of treatment with nucleoside analogues could be indicators of reduced risk for hepatocellular carcinoma.

A recent study has highlighted a concerning gender disparity in access to liver transplants showing that women on the liver transplant waiting list are less likely to undergo a transplant

A lot has changed within the Progressive Familial Intrahepatic Cholestasis (PFIC) landscape in the last few years. The introduction of…

A new study found that vitamin E supplementation can significantly improve liver health in adults with metabolic dysfunction-associated steatotic liver disease.

A recent study demonstrated an AI model that can accurately predict tacrolimus concentrations and suggest optimal dosing for liver transplant recipients.

Recent studies suggest liver stiffness as the primary indicator for assessing long-term risk after Hepatitis C virus treatment